AI-enabled medical devices increasingly depend on software updates, model evolution, and continuous security maintenance, yet conventional DevOps does not satisfy the traceability, accountability, and governance obligations required for safety-critical regulation. This paper introduces BioDevOps, a framework-in-progress for continuous validation and deployment in regulated biomedical systems. The current contribution combines a four-layer UML architecture, a compact formalization of governance invariants, and a small deployment scenario illustrating how runtime risk signals are transformed into governance evidence before release decisions are made. It also identifies the minimal semantic ingredients required for later verification-oriented encoding. More specifically, the paper makes explicit the separation between automated evidence production and human-controlled release authorization, and frames this separation as the key condition for reconciling adaptive software evolution with accountable regulatory oversight.

PhD Forum: BioDevOps: Toward a Formal Framework for Continuous Deployment in Safety-Critical Medical Devices

Fabio Orazio Mirto
2026-01-01

Abstract

AI-enabled medical devices increasingly depend on software updates, model evolution, and continuous security maintenance, yet conventional DevOps does not satisfy the traceability, accountability, and governance obligations required for safety-critical regulation. This paper introduces BioDevOps, a framework-in-progress for continuous validation and deployment in regulated biomedical systems. The current contribution combines a four-layer UML architecture, a compact formalization of governance invariants, and a small deployment scenario illustrating how runtime risk signals are transformed into governance evidence before release decisions are made. It also identifies the minimal semantic ingredients required for later verification-oriented encoding. More specifically, the paper makes explicit the separation between automated evidence production and human-controlled release authorization, and frames this separation as the key condition for reconciling adaptive software evolution with accountable regulatory oversight.
2026
9798319542076
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3365358
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact